Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

73 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Intensity-modulated arc therapy with cisplatin as neo-adjuvant treatment for primary irresectable cervical cancer. Toxicity, tumour response and outcome.
Vandecasteele K, Makar A, Van den Broecke R, Delrue L, Denys H, Lambein K, Lambert B, van Eijkeren M, Tummers P, De Meerleer G. Vandecasteele K, et al. Among authors: van eijkeren m, van den broecke r. Strahlenther Onkol. 2012 Jul;188(7):576-81. doi: 10.1007/s00066-012-0097-0. Epub 2012 Apr 19. Strahlenther Onkol. 2012. PMID: 22526231 Clinical Trial.
Postoperative intensity-modulated arc therapy for cervical and endometrial cancer: a prospective report on toxicity.
Vandecasteele K, Tummers P, Makar A, van Eijkeren M, Delrue L, Denys H, Lambert B, Beerens AS, Van den Broecke R, Lambein K, Fonteyne V, De Meerleer G. Vandecasteele K, et al. Among authors: van eijkeren m, van den broecke r. Int J Radiat Oncol Biol Phys. 2012 Oct 1;84(2):408-14. doi: 10.1016/j.ijrobp.2011.12.020. Epub 2012 Feb 28. Int J Radiat Oncol Biol Phys. 2012. PMID: 22377596
Combining high dose external beam radiotherapy with a simultaneous integrated boost to the dominant intraprostatic lesion: Analysis of genito-urinary and rectal toxicity.
Sundahl N, De Meerleer G, Villeirs G, Ost P, De Neve W, Lumen N, De Visschere P, Van Eijkeren M, Fonteyne V. Sundahl N, et al. Among authors: van eijkeren m. Radiother Oncol. 2016 Jun;119(3):398-404. doi: 10.1016/j.radonc.2016.04.031. Epub 2016 May 6. Radiother Oncol. 2016. PMID: 27162160
Adoption of single fraction radiotherapy for uncomplicated bone metastases in a tertiary centre.
Peters C, Vandewiele J, Lievens Y, van Eijkeren M, Fonteyne V, Boterberg T, Deseyne P, Veldeman L, De Neve W, Monten C, Braems S, Duprez F, Vandecasteele K, Ost P. Peters C, et al. Among authors: van eijkeren m. Clin Transl Radiat Oncol. 2021 Jan 15;27:64-69. doi: 10.1016/j.ctro.2021.01.004. eCollection 2021 Mar. Clin Transl Radiat Oncol. 2021. PMID: 33532632 Free PMC article.
Incidence and radiotherapy treatment patterns of complicated bone metastases.
Peters C, Vandewiele J, Lievens Y, van Eijkeren M, Fonteyne V, Boterberg T, Deseyne P, Veldeman L, De Neve W, Monten C, Braems S, Duprez F, Vandecasteele K, Ost P. Peters C, et al. Among authors: van eijkeren m. J Bone Oncol. 2023 Dec 23;44:100519. doi: 10.1016/j.jbo.2023.100519. eCollection 2024 Feb. J Bone Oncol. 2023. PMID: 38179260 Free PMC article.
73 results